A detailed history of Goldstein Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Goldstein Advisors, LLC holds 2,187 shares of NTRA stock, worth $264,539. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,187
Previous 2,838 22.94%
Holding current value
$264,539
Previous $307 Million 9.66%
% of portfolio
0.04%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$97.75 - $129.67 $63,635 - $84,415
-651 Reduced 22.94%
2,187 $278 Million
Q2 2024

Jul 24, 2024

SELL
$85.28 - $112.6 $45,624 - $60,241
-535 Reduced 15.86%
2,838 $307 Million
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $199,715 - $313,351
3,373 New
3,373 $308 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $11.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Goldstein Advisors, LLC Portfolio

Follow Goldstein Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldstein Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goldstein Advisors, LLC with notifications on news.